Indogulf Cropsciences IPO GMP Analysis: Is the Grey Market Buzz Justified?

abhi finowingsabhi finowings
4 min read

The agrochemical sector is buzzing with excitement as Indogulf Cropsciences Limited launches its Initial Public Offering (IPO). With a robust background in crop protection products and a diversified global customer base, this IPO is drawing serious attention from retail and institutional investors alike. A key highlight? The Indogulf Cropsciences IPO GMP (Grey Market Premium), which gives early insight into investor sentiment.

Let’s dive into the complete breakdown of this IPO — covering the price band, issue size, GMP, subscription status, allotment timeline, and more.


About Indogulf Cropsciences Ltd

Indogulf Cropsciences is a Delhi-based agrochemical company that manufactures and markets a broad range of products including insecticides, herbicides, fungicides, and plant growth regulators. The company operates in both domestic and international markets and holds ISO 9001:2015 and other quality certifications. With an increasing demand for agri-inputs in India and abroad, the company is poised for further expansion.


Indogulf Cropsciences IPO: Key Details

IPO DetailsInformation
Price Band₹105 to ₹111 per share
Face Value₹10 per share
Lot Size135 shares
Minimum Investment₹14,985 (1 lot at ₹111)
Issue Size₹200 crore
Fresh Issue₹160 crore
Offer for Sale (OFS)₹40 crore
IPO Opening DateJune 26, 2025
IPO Closing DateJune 30, 2025
Allotment DateJuly 1, 2025 (Tentative)
Listing DateJuly 3, 2025 (Expected on BSE & NSE)
Anchor Investment Raised₹58.19 crore on June 25 at ₹111/share

Grey Market Premium (GMP) Update

The Indogulf Cropsciences IPO GMP is currently hovering around ₹10–₹11 per share. This implies an expected listing price of around ₹121–₹122, signaling moderate interest in the grey market.

Although GMP is not an official indicator and remains speculative, it often reflects the real-time market buzz and expected listing gain. A GMP of ~₹11 on the upper price band of ₹111 represents nearly a 10% listing premium.


Subscription Status (As of Day 1)

The IPO opened on June 26, 2025, and here’s how investors responded on Day 1:

  • Total Subscription: ~40%

  • Retail Investors: 60%–69% subscribed

  • Non-Institutional Investors (NII): ~22%

  • Qualified Institutional Buyers (QIBs): ~5%

These figures suggest a stronger interest from retail investors, a common pattern in SME and agrochemical IPOs. QIB participation is likely to pick up closer to the final day.


Use of IPO Proceeds

Indogulf plans to utilize the IPO proceeds for the following:

  • Working Capital: ₹65 crore

  • Debt Repayment: ₹34.12 crore

  • Setting up a Dry Flowable Plant in Haryana: ₹14 crore

  • General Corporate Purposes: Remaining funds

This deployment shows a balanced focus on growth expansion and financial strengthening, which enhances long-term value for shareholders.


Industry & Peer Comparison

Indogulf operates in a competitive sector with listed peers like:

  • UPL Ltd

  • Rallis India

  • Dhanuka Agritech

  • Insecticides (India) Ltd

Compared to these, Indogulf’s valuation appears modest, especially given its expansion plans and growing revenue base. Investors must look closely at its financials in the red herring prospectus to judge profitability and scalability.


Should You Apply?

Here’s a quick checklist to help you decide:

GMP of ₹10–₹11 suggests early listing gains
Focused use of proceeds in expansion and debt reduction
Strong retail subscription on Day 1
⚠️ Moderate QIB interest may need closer tracking
⚠️ Check full financials before applying heavily

If you’re a retail investor looking for medium-term returns or potential listing gains, this IPO appears promising — especially in a growing sector like agrochemicals.


Final Thoughts

The Indogulf Cropsciences IPO GMP clearly reflects positive investor sentiment. While grey market trends are encouraging, always evaluate the fundamentals, industry trends, and peer valuation before making a final decision. The IPO is well-structured, with a clear growth trajectory, and could be a strong contender in the SME space if listing sentiment holds.

0
Subscribe to my newsletter

Read articles from abhi finowings directly inside your inbox. Subscribe to the newsletter, and don't miss out.

Written by

abhi finowings
abhi finowings